Just stumbled upon this company on Small Cats. $35m MC for a company about to begin two Ph2 trials does seem low, does anyone have a read on the TAM for these conditions?
I think that what is perhaps going against them is that trials will take 2 years to complete. What do you all see as the inflection points in 2022? How soon can interim results be announced? If it's 2023 then not sure you will have the punters back until then. Would love to know more about this company if there are any other links you could bring to my attention, will keep researching myself anyway.
Cheers & Goodluck
Ann: Amplia Provides Updated Investor Presentation, page-32
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
